Skip to content
10-Q

Quarterly Report

CANCER CAPITAL CORP.

0001554795-22-000287

← back to feed
Filed
Aug 12, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 12, 2022 6.15M sh
Cash And Equivalents Q2 2022 · Jun 30, 2022 $20.45K
Cash And Equivalents Q2 2022 · Dec 31, 2021 $62
Cash And Equivalents Q2 2022 · Jun 30, 2021 $1.2K
Cash And Equivalents Q2 2022 · Dec 31, 2020 $698
Current Liabilities Q2 2022 · Jun 30, 2022 $412.04K
Current Liabilities Q2 2022 · Dec 31, 2021 $369.19K
Total Liabilities Q2 2022 · Jun 30, 2022 $412.04K
Total Liabilities Q2 2022 · Dec 31, 2021 $369.19K
Current Assets Q2 2022 · Jun 30, 2022 $20.45K
Current Assets Q2 2022 · Dec 31, 2021 $62
Total Assets Q2 2022 · Jun 30, 2022 $20.45K
Total Assets Q2 2022 · Dec 31, 2021 $62
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$3.2K
Stockholders Equity Q2 2022 · Jun 30, 2021 −$350.61K
Stockholders Equity Q2 2022 · Mar 31, 2021 −$342.23K
Stockholders Equity Q2 2022 · Dec 31, 2020 −$332.34K
Sga Expense Q2 2022 · Jun 30, 2021 $3.8K
Sga Expense Q2 2022 · Jun 30, 2021 $9.2K
Net Income Q2 2022 · Jun 30, 2021 −$8.37K
Net Income Q2 2022 · Jun 30, 2021 −$18.27K
Net Income Q2 2022 · Mar 31, 2021 −$9.89K
Operating Income Q2 2022 · Jun 30, 2021 −$3.8K
Operating Income Q2 2022 · Jun 30, 2021 −$9.2K